Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TAAG Genetics is a global biotechnology company specializing in the development and commercialization of advanced molecular diagnostic solutions. The company leverages its proprietary multiplex PCR technology and artificial intelligence platforms to provide rapid, accurate testing for food safety, environmental monitoring, and clinical diagnostics. TAAG Genetics offers a comprehensive suite of services including pathogen detection, genetic analysis, and customized laboratory workflows. With a strong presence in Latin America and North America, the company serves diverse industries ranging from food production to healthcare providers. Their integrated approach combines high-throughput laboratory services with cloud-based data management to optimize diagnostic efficiency. The company's TxH technology allows for the simultaneous detection of multiple targets, significantly reducing turnaround times for critical results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TAAG Genetics.